Stephens analyst Scott Fidel lowered the firm’s price target on Acadia Healthcare to $88 from $92 and keeps an Equal Weight rating on the shares. Acadia delivered strong same-store growth results in Q4, but core base wage inflation has been creeping higher over the past two quarters, the firm tells investors. While "enthusiastic" about Acadia’s growth strategy, the firm said the long-term financial algorithm assumes continued margin expansion, leaving "limited cushion for higher expense growth."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACHC: